Bank Of Montreal Maravai Lifesciences Holdings, Inc. Transaction History

Bank Of Montreal

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$6.87 - $11.34 $22,609 - $37,319	3,291 Added 13.7%	27,306 $195,000
Q1 2024 May 13, 2024	SELL	$5.11 - $8.76 $45,990 - $78,840	-9,000 Reduced 27.26%	24,015 $208,000
Q4 2023 Feb 08, 2024	BUY	$4.7 - $9.87 $155,170 - $325,858	33,015 New	33,015 $216,000
Q1 2023 Jun 13, 2024	BUY	$12.99 - $16.48 $343,754 - $436,110	26,463 Added 110.19%	50,478 $707,000
Q3 2022 Nov 10, 2022	BUY	$20.6 - $30.37 $59,348 - $87,495	2,881 Added 12.28%	26,336 $674,000
Q2 2022 Aug 11, 2022	BUY	$26.05 - $37.48 $179,536 - $258,312	6,892 Added 41.61%	23,455 $654,000
Q1 2022 May 12, 2022	BUY	$24.46 - $40.92 $48,577 - $81,267	1,986 Added 13.62%	16,563 $591,000
Q4 2021 Feb 11, 2022	SELL	$35.0 - $45.94 $22,960 - $30,136	-656 Reduced 4.31%	14,577 $613,000
Q3 2021 Nov 12, 2021	SELL	$36.8 - $60.62 $394,753 - $650,270	-10,727 Reduced 41.32%	15,233 $738,000
Q2 2021 Aug 12, 2021	BUY	$32.46 - $45.0 $842,661 - $1.17 Million	25,960 New	25,960 $1.12 Million

235

141M

223K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $746M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.